BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Business

  Johnson & Johnson’s Janssen Biotech Inc. Licenses LADD From Bay Area’s Aduro Biotech In Deal Worth $365 Million

  May 29, 2014

   · 

  2 min read
• BioMidwest

  Spectranetics Corporation Announces Pricing Of $200 Million Convertible Senior Notes Offering

  May 29, 2014

   · 

  4 min read
• FDA

  Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) Rises On FDA Approval For Natesto™ Nasal Gel

  May 29, 2014

   · 

  6 min read
• Job Trends

  Greatbatch, Inc. To Move 170 Jobs To Mexico

  May 29, 2014

   · 

  1 min read
• FDA

  Nuvo Research Inc. Announces FDA Approval Of Third-Party Generic Of PENNSAID 1.5%

  May 29, 2014

   · 

  9 min read
• Drug Development

  Boston Therapeutics, Inc. Initiates Phase 2b Study To Assess The Efficacy And Safety Of SUGARDOWN® For Type 2 Diabetes

  May 29, 2014

   · 

  5 min read
• Business

  Oncothyreon Inc. And Celldex Therapeutics, Inc. Announce Collaboration For Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab

  May 29, 2014

   · 

  8 min read
• Business

  Vital Therapies, Inc. (VTI) Announces First Quarter 2014 Financial Results And Provides Operational Update

  May 29, 2014

   · 

  9 min read
• Genetown

  Arch Therapeutics To Present At The LD MICRO Invitational 2014 On June 4th

  May 29, 2014

   · 

  3 min read
• Policy

  Adamis Pharmaceuticals New Drug Application To FDA For Its Epinephrine Pre-Filled Syringe

  May 29, 2014

   · 

  4 min read